2nd How to Diagnose and Treat
CML / MPN
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa

2nd How to Diagnose and Treat
CML / MPN
Information
ABOUT THE CONFERENCE:
This second meeting organized by ESH to focus in depth upon the clinical management of patients with chronic myeloid leukemia and the myeloproliferative neoplasms, builds on the experiences and scientific progress since the highly successful Inaugural “How to Treat CML and MPN” held in Dublin in March 2019. This “ 2nd How to Diagnose and Treat CML and MPN” uses a case-based format to scrutinise with experts in the field relevant issues in diagnosis, prognostication, therapy selection, efficacy assessment, and management of toxicities for these patients. The format for this meeting will be highly interactive with a mixture of case-based didactic lectures, roundtable discussions regarding challenging clinical scenarios, and debates on controversial areas of management. This first ESH meeting for MPN occurring since the onset of the COVID19 Pandemic will cover the specific patient implications for CML and MPN patients. The faculty for this event represent the clinical and scientific leaders of the MPN community from around the world and we anticipate great opportunities for interactions and discussions. Clinical haematologists, hematology nurses, clinician scientists, hematology investigators, and those in training will find great value in attending and participating in this event.
SCIENTIFIC TOPICS:
• Optimizing cytoreduction
• Management of CML with TKI
• MPN risk stratification including vascular events
• Evolving therapies in Myelofibrosis
• Management of advanced disease (MPN and CML)
• Treatment free remission in CML
Programme
Read the final programme!



